Subthreshold Micro-Pulse Yellow Laser and Eplerenone Drug Therapy in Chronic Central Serous Chorio-Retinopathy Patients: A Comparative Study. (18th May 2020)

• Record Type: Journal Article
• Authors: Vignesh, T. P.; Maitray, Aditya; Sen, Sagnik; Chakrabarti, Anirban; Kannan, Naresh Babu; Ramasamy, Kim
• Is Part Of: Seminars in ophthalmology. Volume 35:Number 4(2020)
• Page Start: 237
• Page End: 245
• Publication Date: 2020-05-18
• Subjects: Chronic central serous chorioretinopathy -- cCSCR -- subthreshold micropulse yellow laser -- eplerenone -- laser; Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; Eye -- Surgery -- Periodicals; 617.7005
• DOI: 10.1080/08820538.2020.1809682
• Languages: English
• ISSNs: 0882-0538

Abstract

ABSTRACT: Purpose: To study the outcomes of subthreshold micropulse yellow laser (SML) and eplerenone (EP) therapy in central serous chorio-retinopathy (cCSCR) Methods: Retrospective study of 28 eyes of 27 patients undergoing SML and 20 eyes of 19 patients undergoing EP therapy Results: Median duration of follow-up was 8 months for SML and 4.5 months for EP group. Complete SRF resolution was seen in 12/28 (42.8%) eyes in SML and 4/20 (20%) in EP group. Six eyes in SML group and two eyes in EP group needed additional SML. No EP patients demonstrated hyperkalemia warranting stopping of therapy. Baseline visual acuity (VA) was correlated positively with final VA in both groups. Presence/absence of focal leaks had differing outcomes in both treatment groups in terms of anatomical resolution. Conclusion: Both treatment modalities were effective in the management of cCSCR showing comparable favorable anatomical outcomes, but visual outcomes were not significant, probably due to chronicity of the pathology.